TRAX
First Tracks Biotherapeutics
NASDAQ: TRAX · HEALTHCARE · BIOTECHNOLOGY
$23.27
-1.57% today
Updated 2026-04-30
Market cap
$821.46M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.71
Dividend yield
—
52W range
$11 – $27
Volume
0.7M
First Tracks Biotherapeutics (TRAX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |